Funding

Recent

• Nov 11

  Proximal Ventures raises debut fund to back startups bringing AI to drug development

  Proximal Ventures announced a debut fund of $27.5 million to support startups applying AI to drug development. The fund focuses on early-stage companies in the pharmaceutical sector. This capital injection may accelerate AI-driven discovery and reduce time to market for new therapies.

  Why it matters: It provides early-stage pharma AI startups with capital that can shorten development timelines and lower costs.

• Nov 4

  Ted Schlein’s Ballistic Ventures seeks $490M for new funds amid AI-driven cybersecurity boom

  Ballistic Ventures is seeking $360 million for a new flagship fund and $130 million for a separate investment vehicle. The firm focuses investments on cybersecurity startups.

  Why it matters: This capital allocation indicates shifting venture investment patterns within the cybersecurity sector, potentially increasing available funding for early-stage security tools.

• Oct 28

  Guidewire buys Hyperexponential for $1.7B in cash

  Guidewire acquired Hyperexponential for $1.7B in cash, aiming to integrate AI agents that work alongside humans to underwrite, analyze, and price decisions. The acquisition is expected to close next year and will enable Guidewire to enhance its underwriting platform with AI-driven decision support.

  Why it matters: The acquisition expands Guidewire’s AI capabilities, potentially reducing underwriting cycle time and improving pricing accuracy for insurers.